Mama, Jane Zainab .

HRN: 22-00-78  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/01/2022
10/07/2022
IV
70mg
OD
PCAP-C; UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: